Please do not leave this page until complete. This can take a few moments.
New Haven-based biotech Arvinas Inc. has signed a licensing agreement with Swiss drugmaker Novartis AG that could be worth up to $1.01 billion, the company announced Thursday.
Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses.
MannKind Corp., a Danbury-based company that develops inhaled therapeutic products, has named a new chief financial officer.
BioXcel Therapeutics Inc., a New Haven-based biopharmaceutical company that uses artificial intelligence to develop medicines in neuroscience and immuno-oncology, on Monday announced a $25 million registered direct offering.
Arvinas Inc. has appointed Dr. Noah Berkowitz as chief medical officer and added him to its executive committee, the New Haven-based biotech company said this week.
A nonprofit biotechnology company formerly based in Boston will celebrate its relocation to Connecticut this weekend.
The U.S. Food and Drug Administration earlier this month approved an application from a New Haven-based biotechnology company to conduct clinical research on a new treatment for Parkinson’s disease.
Under Vlad Coric’s leadership, Biohaven Pharmaceuticals’ blockbuster migraine drug Nurtec ODT became a top-prescribed migraine medicine in its class in the United States.
Arvinas may be one of Connecticut’s most promising clinical-stage life science companies. The New Haven-based biotech is led by John Houston, who has helped the company reach several important milestones.
Jacqueline Heard’s startup company is at the heart of the data-driven agriculture movement, applying artificial intelligence to developing a new generation of pesticides that she hopes will meet the tough challenges facing farmers who must feed a
New Haven-based biotech company Arvinas Inc. announced that its chief financial officer and treasurer, Sean Cassidy, will leave on Feb. 29 and that it has launched a search for a permanent replacement.
Azitra Inc., a Branford-based biopharmaceutical firm, announced Tuesday discounted pricing for a public offering that aims to raise $5 million.
Less than a week after announcing plans to raise $60 million from inventors, New Haven-based BioXcel Therapeutics Inc.
New Haven-based biotech firm Cybrexa Therapeutics has regained all of the rights to a drug that targets cancerous tumors after a California-based firm ended a deal to acquire them.
BioXcel Therapeutics Inc. a New Haven-based biopharmaceutical company, announced a $60 million proposed public offering on Thursday.
The U.S. Food and Drug Administration has granted Fast Track designation to a new breast cancer treatment from Arvinas Inc. and Pfizer Inc., the companies announced Tuesday.
As the manufacturing landscape evolves, many businesses are turning to automation and robotics to address labor shortages and enhance efficiency.
The 2024 Connecticut Manufacturing Report recently found that 87% of manufacturers surveyed said the cost of doing business was increasing. Meantime, 80% of manufacturers in the state said it was difficult to find and retain workers.
Large manufacturers in Connecticut, such as Sikorsky and Pratt & Whitney, have been progressively integrating robotics into their production lines and maintenance operations for years.
A state official recently told the Hartford Business Journal that small and medium-size players are employing creative solutions as well.
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read HereThis special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy